医生应该和他们的病人谈论安慰剂效应吗?

临床和实验室研究表明，安慰剂和反安慰剂效应在给予惰性和积极治疗后影响各种症状和条件。对于如何在临床实践中告知患者安慰剂和反安慰剂效应，以及培训临床医生如何披露这些信息，越来越需要最新的建议。

根据先前关于安慰剂和诺克斯效应的临床建议，通过开放和封闭式的调查问题进行了一项研究，然后是最终的专家会议组成。调查被细分为3部分：（1）通知耐心关于安慰剂效应，（2）通知患者关于NOCEBO效应，（3）培训临床医生如何向患者传达这些信息。

The results of the surveys showed that there was consensus on communicating general information about placebo and nocebo effects to patients (e.g., explaining their role in treatment) could be beneficial, but that such information needs to be adjusted to match the specific clinical context (e.g., condition and treatment). Experts also agreed that training clinicians to communicate about placebo and nocebo effects should be a regular and integrated part of medical education that makes use of multiple formats, including face-to-face and online modalities.

目前的研究为有关信息的披露提供了基于协商一致意见的建议和实际考虑安慰剂和nocebo效应临床实践．如何在如何最佳地定制信息以及特定的临床条件和患者需求，以及为临床医生开发标准化披露培训模块的未来研究。

---

---